EXTON, Pa., Aug. 6 /PRNewswire/ -- Melior Discovery, Inc. today announced that it has signed an agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) to apply Melior's theraTRACE(SM) indications discovery platform to identify possible new indications for multiple J&JPRD drug candidates. Financial terms were not disclosed.
